Walleye Trading
IDXG

Walleye Trading’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Walleye Trading’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4
Closed – – 5194
2017
Q1 		$0 Hold
4
– – ﹤0.01% 5360
2016
Q4 		$0 Hold
4
– – ﹤0.01% 5412
2016
Q3 		$0 Hold
4
– – ﹤0.01% 5702
2016
Q2 		$0 Hold
4
– – ﹤0.01% 5921
2016
Q1 		$0 Hold
4
– – ﹤0.01% 6064
2015
Q4 		$0 Hold
4
– – ﹤0.01% 5922
2015
Q3 		$1K Buy
+4
New +$788 ﹤0.01% 4860

Other funds holding IDXG

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wedbush Securities
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Glenmede Trust
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Raymond James & Associates
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Walleye Trading's IDXG Position: Q2 2017 in Review

Walleye Trading sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q2 2017, closing a stake of 4 shares.

Walleye Trading first reported a position in IDXG in Q3 2015 and held it in 7 quarters. The position peaked at $1K in Q3 2015. 17 funds tracked by Wall St. Rank hold IDXG as of Q2 2017.

  • Walleye Trading reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 4 Interpace Biosciences, Inc. Common Stock shares in Q2 2017.
  • Walleye Trading first reported a position in Interpace Biosciences, Inc. Common Stock in Q3 2015 and held it in 7 quarters.
  • Walleye Trading's Interpace Biosciences, Inc. Common Stock position peaked at $1K in Q3 2015.
  • 17 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.